Overview

Metformin in Postmenopausal Women With Metabolic Syndrome

Status:
Unknown status
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects of metformin on cardiovascular risk factors in postmenopausal women with metabolic syndrome.
Phase:
Phase 4
Details
Lead Sponsor:
Mahidol University
Treatments:
Metformin